The role of EGFR in KRASG12D-driven tumorigenesis was studied using mouse CRC organoids with KRAS-APC-TP53 mutations and ...

Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...

The potential of computational chemistry to revolutionise cancer treatment in Nigeria represents a paradigm shift in medical ...

In the recent study, Ramalingam found that people with Stage III lung cancer who had EGFR mutations had an 84% lower risk of ...

UB medicinal chemist David Heppner has received the 2025 Philip S. Portoghese Lectureship Award from the American Chemical ...

The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients ...

EGFR and HER3 are members of the human epidermal growth factor receptor (HER) family and are validated therapeutic targets in advanced solid tumors. EGFR overexpression drives tumor progression in ...

Following announcement of prioritized development strategy for evorpacept in combination with anti-cancer antibodies at R&D ...

Epidermal Growth Factor Receptor (EGFR) is a protein involved in cell growth, division and survival. Mutations in the EGFR gene lead to the over-production of EGFR proteins on some types of cancer ...

This Vectibix (panitumumab) market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the ...

BUFFALO, N.Y. — University at Buffalo medicinal chemist David Heppner has received the 2025 Philip S. Portoghese Lectureship ...

AstraZeneca Partners with Revna Biosciences to Enhance Epidermal Growth Factor Receptor (EGFR) Biomarker Testing in Ghana ...